The Gross Margin of Evoke Pharma Inc (EVOK) is 96.52%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 96.52% |
| 2023-12-31 | 96.10% |
| 2022-12-31 | 85.26% |
| 2021-12-31 | 79.63% |
| 2020-12-31 | -350.00% |